自拟益气通络汤治疗椎动脉型颈椎病（气血亏虚型）的临床研究

《自拟益气通络汤治疗椎动脉型颈椎病（气血亏虚型）的临床研究》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、学校代号10199学号20124120101硕士学位论文自拟益气通络汤治疗椎动脉型颈椎病（气血亏虚型）的临床研究学位申请人寇斌导师姓名职称李跃飞教授专业名称中医骨伤科学研究方向脊柱培养方式全日制申请学位类型专业学位论文提交日期2015年4月分类号密级ＵＤＣ编号硕±学位论义自拟益气通络汤治皆椎动脉型颈椎病（气血亏虚型）的临床研究寇斌指导教师姓名：李跃飞教授（长春中医药大学附属医院）申请学位级别：硕±专业名称：中医骨伤科学研究方向：脊柱论文提交日期：２０１５年４月论文答辩日期：２０１５年６月学位授予单位：长春

2、中医药大学提交碗认：作者答名长春中医药大学学位论文原创性声明工作所取得的成果。本人郑重声明：所呈交的学位论文，是个人在导师的指导下，独立进行研究除文中已经特别加ｋ义注明引用的内容外，本论文不含任何其他个人或集体巳经发表或撰写过的作品成果。对本文的研究做出重要贡献的个人和集体，均已在文中明确方式标明并致谢。本人完全意识到本声明的法律结果由本人承担。学位论义作者答名苗成＞以户文年／月ｒ曰关于学位论文知识产权归属的声明本人巧重声明：所呈交的学位论文，是本人在导师指导下自选课题或导师承担的国家立项资助的计划课题的一部分，系本人在导

3、师指导和资助下独立进行研究工作所取得的成果，知识产权归属权为长春中医药大学和本人导师所有一。特此声明切法律责任由本人承担。，本声明的论文作者签名指导教师签名＿＇。疋（知／月３曰关于学位论文使用授权的声明本人完全了解长春中医药大学有关保留使用学位论文的规定，同意学校保留并向有关机构送交论文的复印件和电子版，允许被查阁和借阅。本人授权长春中医药大学可ａ将本学位论文的全部或部分内容编入有关数据库进行检索１１，可＾采用影印、缩印或其他复巧手段保存和汇编本学位论文。（保密论文在解密后应遵守此规定）论文作者签名骇城）签名＿＿指导教师

4、＞作年／月ｒ曰长春中医药大学2012届硕士学位论文目录目录中文摘要·······························································································1英文摘要·······························································································2英文缩略语··················································

5、··········································3前言·······························································································4文献综述·······························································································51中医关于颈椎病（椎动脉型）的认识····························

6、···························52现代医学关于颈椎病（椎动脉型）发病机制的认识·····································63颈椎病（椎动脉型）的诊断··································································84颈椎病（椎动脉型）的治疗··································································105总结与展望······························

7、·························································15临床研究·······························································································171一般资料··························································································172试验病例参照标准··················